Oncotarget

Research Papers: Pathology:

Combination of exercise training and erythropoietin prevents cancer-induced muscle alterations

Fabrizio Pin, Silvia Busquets, Miriam Toledo, Andrea Camperi, Francisco J. Lopez-Soriano, Paola Costelli, Josep M. Argilés and Fabio Penna _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:43202-43215. https://doi.org/10.18632/oncotarget.6439

Metrics: PDF 1196 views  |   HTML 1156 views  |   ?  


Abstract

Fabrizio Pin1,*, Silvia Busquets2,3,*, Miriam Toledo2, Andrea Camperi1, Francisco J. Lopez-Soriano2,3, Paola Costelli1, Josep M. Argilés2,3,** and Fabio Penna1,**

1 Department of Clinical and Biological Sciences, University of Torino, Torino, Italy

2 Cancer Research Group, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain

3 Institut de Biomedicina de la Universitat de Barcelona (IBUB), Barcelona, Spain

* First author equal contribution

** Last author equal contribution

Correspondence to:

Fabio Penna, email:

Keywords: cancer cachexia, exercise training, erythropoietin, PGC-1α, mitochondria, Pathology Section

Received: August 07, 2015 Accepted: November 21, 2015 Published: November 30, 2015

Abstract

Cancer cachexia is a syndrome characterized by loss of skeletal muscle mass, inflammation, anorexia and anemia, contributing to patient fatigue and reduced quality of life. In addition to nutritional approaches, exercise training (EX) has been proposed as a suitable tool to manage cachexia. In the present work the effect of mild exercise training, coupled to erythropoietin (EPO) administration to prevent anemia, has been tested in tumor-bearing mice. In the C26 hosts, acute exercise does not prevent and even worsens muscle wasting. Such pattern is prevented by EPO co-administration or by the adoption of a chronic exercise protocol. EX and EPO co-treatment spares oxidative myofibers from atrophy and counteracts the oxidative to glycolytic shift, inducing PGC-1α. LLC hosts are responsive to exercise and their treatment with the EX-EPO combination prevents the loss of muscle strength and the onset of mitochondrial ultrastructural alterations, while increases muscle oxidative capacity and intracellular ATP content, likely depending on PGC-1α induction and mitophagy promotion. Consistently, muscle-specific PGC-1α overexpression prevents LLC-induced muscle atrophy and Atrogin-1 hyperexpression. Overall, the present data suggest that low intensisty exercise can be an effective tool to be included in combined therapeutic approaches against cancer cachexia, provided that anemia is coincidently treated in order to enhance the beneficial action of exercise.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 6439